Shortcomings of pertussis vaccines: why we need a third generation vaccine

Pertussis Vaccine Performance in an Epidemic Year--Oregon, 2012

(2014) J. Liko et al.   CLINICAL INFECTIOUS DISEASES

Bordetella pertussisand pertactin-deficient clinical isolates: lessons for pertussis vaccines

(2014) Nicolas Hegerle et al.   Expert Review of Vaccines

Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants

(2014) Flor M. Munoz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers

(2014) Rigmor Thorstensson et al.   PLoS One

Toward a new vaccine for pertussis

(2014) John B. Robbins et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Quantification of the Adenylate Cyclase Toxin of Bordetella pertussisIn Vitroand during Respiratory Infection

(2013) Joshua C. Eby et al.   INFECTION AND IMMUNITY

Priming with Whole-Cell versus Acellular Pertussis Vaccine

(2013) Juventila Liko et al.   NEW ENGLAND JOURNAL OF MEDICINE

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

(2012) Sarah L. Sheridan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

An improved whole cell pertussis vaccine with reduced content of endotoxin

(2012) Waldely Dias et al.   Human Vaccines & Immunotherapeutics

Bordetella parapertussis isolates not expressing pertactin circulating in France

(2010) V. Bouchez et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pertussis vaccine encephalopathy: ‘Oh! Let us never, never doubt …

(2010) PETER BAXTER   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY